Search
for
Sort by
Research 301–330 of 1000+
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- Global sex disparities in lifetime risk of alopecia areata: a systematic analysis from the global burden of disease study, 1990 to 2021
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- Androgenetic Alopecia: An Update on Pathogenesis and Pharmacological Treatment
- Immune and Non-immune Interactions in the Pathogenesis of Androgenetic Alopecia
- Male androgenetic alopecia
- Exploring links between acne and metabolic syndrome: a narrative review
- Pathogenesis and management of TRPV3-related Olmsted syndrome
- Androgenic alopecia is associated with higher dietary inflammatory index and lower antioxidant index scores
- Cell death as an architect of adult skin stem cell niches
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Targeted immunotherapy for hair regrowth and regeneration
- Neuropathic Pruritus: An Underrecognized and Often Misdiagnosed and Difficult to Treat Medical Condition
- Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients
- A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- In Human Skin, UVB Initiates Early Induction of IL-10 Over IL-12 Preferentially in the Expanding Dermal Monocytic/Macrophagic Population
- Bacteria induce skin regeneration via IL-1β signaling
- IL-1 Receptor–Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation
- Proprietary Herbal Extract Downregulates the Gene Expression of Il-1 and #945; in HaCaT Cells: Possible Implications Against Nonscarring Alopecia
- Serum levels of interleukin-1 (IL-1α, IL-1β) in patients with alopecia areata
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- 1,25-(OH)2D3 promotes hair growth by inhibiting NLRP3/IL-1β and HIF-1α/IL-1β signaling pathways
- Interleukin-25-Mediated-IL-17RB Upregulation Promotes Cutaneous Wound Healing in Diabetic Mice by Improving Endothelial Cell Functions
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- Tannic Acid Accelerates Cutaneous Wound Healing in Rats Via Activation of the <i>ERK 1/2</i> Signaling Pathways